CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses

Radiomics: the bridge between medical imaging and personalized medicine

(2017) Philippe Lambin et al.   Nature Reviews Clinical Oncology

Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas

(2016) Ying Liu et al.   Clinical Lung Cancer

Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non—Small Cell Lung Cancer

(2016) Yanqi Huang et al.   RADIOLOGY

The Potential of Radiomic-Based Phenotyping in Precision Medicine

(2016) Hugo J. W. L. Aerts   JAMA Oncology

CT Gray-Level Texture Analysis as a Quantitative Imaging Biomarker of Epidermal Growth Factor Receptor Mutation Status in Adenocarcinoma of the Lung

(2015) Efe Ozkan et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer

(2015) Stefania Rizzo et al.   EUROPEAN RADIOLOGY

Genomic alterations in lung adenocarcinoma

(2015) Siddhartha Devarakonda et al.   LANCET ONCOLOGY

Radiomics: Extracting more information from medical images using advanced feature analysis

(2012) Philippe Lambin et al.   EUROPEAN JOURNAL OF CANCER

Radiomics: the process and the challenges

(2012) Virendra Kumar et al.   MAGNETIC RESONANCE IMAGING

Pathology of Lung Cancer

(2011) William D. Travis   CLINICS IN CHEST MEDICINE

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Better survival with EGFR exon 19 than exon 21 mutations in gefitinib-treated non-small cell lung cancer patients is due to differential inhibition of downstream signals

(2008) Jian-quan Zhu et al.   CANCER LETTERS